Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Beta Bionics Inc shares valued at $15,529 were sold by Hopman Mark on Jun 02 ’25. At $17.89 per share, Hopman Mark sold 868 shares. The insider’s holdings dropped to 34,132 shares worth approximately $0.66 million following the completion of this transaction.
Also, Russell Steven Jon sold 1,039 shares, netting a total of over 18,588 in proceeds. Following the sale of shares at $17.89 each, the insider now holds 72,032 shares.
Before that, Mensinger Mike had sold 1,115 shares from its account. In a trade valued at $19,948, the Chief Product Officer traded Beta Bionics Inc shares for $17.89 each. Upon closing the transaction, the insider’s holdings decreased to 1,115 shares, worth approximately $1.81 million.
As published in their initiating research note from Wolfe Research on May 30, 2025, Beta Bionics Inc [BBNX] has been an Outperform and the price target has been revised to $20. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in late May. As of February 24, 2025, Stifel has initiated its “Buy” rating for BBNX. Earlier on February 24, 2025, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for BBNX stock.
Analyzing BBNX Stock Performance
During the last five days, there has been a surge of approximately 34.79%. Over the course of the year, Beta Bionics Inc shares have dropped approximately -17.69%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
According to the 24-hour chart, there is a support level at 18.30, which, if violated, would cause prices to drop to 17.14. In the upper region, resistance lies at 20.03. The next price resistance is at 20.61. RSI (Relative Strength Index) is 70.87 on the 14-day chart, showing overbought technical sentiment.
